Allogene Therapeutics Inc (ALLO) Event June 17, 2022, 20:16 UTC (50% Neutral) Allogene Therapeutics, Inc. (ALLO) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 2, 2025, 8:13 a.m. 📋 Allogene Therapeutics, Inc. (ALLO) - Regulatory Update Filing Date: 2022-06-17 Accepted: 2022-06-17 16:16:42 Event Type: Regulatory Update Event Details: Allogene Therapeutics Inc (ALLO) Announces Regulatory Update Allogene Therapeutics Inc (ALLO) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Allogene Therapeutics IncCIK: 0001737287Ticker Symbol: ALLOPeriod End Date: 2022-06-15Document Type: 8-K
📋 Allogene Therapeutics, Inc. (ALLO) - Regulatory Update
Filing Date: 2022-06-17
Accepted: 2022-06-17 16:16:42
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: